Canagliflozin API Market
Canagliflozin API Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Canagliflozin API Market Size and Growth
The Canagliflozin API market is poised for growth, driven by increasing diabetes prevalence and expanding therapeutic applications. The global market size was valued at approximately $450 million in 2022 and is projected to reach $1 billion by 2030, reflecting a robust compound annual growth rate (CAGR) fueled by heightened demand and innovation. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Dr. Reddy's Laboratories
◍ Metrochem API Private Limited
◍ Sun Pharmaceutical
◍ Zhejiang Huahai Pharmaceutical
◍ Indoco Remedies Ltd.
◍ Lupin Ltd
The Canagliflozin API market features key players like Dr. Reddy's Laboratories, Sun Pharmaceutical, and Lupin, which innovate formulations, enhance production capabilities, and expand market reach. Their contributions drive supply and demand, boosting market growth. Notably, Sun Pharma reported revenue of $4.5 billion, while Lupin generated $2.4 billion.
◍ CAD Middle East Pharmaceutical Industries LLC
◍ Melody Healthcare Pvt Ltd
◍ Changzhou Pharmaceutical Factory
◍ Glenmark Pharmaceuticals
Request Sample Report
Market Segmentation
By Application
By Product
◍ Purity≥98% ◍ Purity<98% ◍ Canagliflozin Tablets ◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
